Determinants of renal volume in autosomal-dominant polycystic kidney disease

Kidney International

Volumn 73, Issue 1, 2008, Pages 108-116

  Grantham, J J ^a,b   Cook, L T ^b   Torres, V E ^c   Bost, J E ^d   Chapman, A B ^e   Harris, P C ^c   Guay Woodford, L M ^f   Bae, K T ^d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Cell growth; Polycystic kidney; Prolifiration cyst volume; Renal cysts; Tubules

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; GROWTH RATE; HUMAN; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROGNOSIS;

EID: 37249043883     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002624     Document Type: Article

References (40)

1. Chapman AB, Guay-Woodford LM, Grantham JJ et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int 2003; 64: 1035-1045.
2. Grantham JJ, Chapman AB, Torres VE. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 2006; 1: 148-157.
3. Harris PC, Torres VE. Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy. Curr Opin Nephrol Hypertens 2006; 15: 456-463.
4. MacDermot KD, Saggar-Malik AK, Economides DL, Jeffery S. Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease. J Med Genet 1998; 35: 13-16.
5. Jeffery S, Saggar-Malik AK, Economides DL et al. Apparent normalisation of fetal renal size in autosomal dominant polycystic kidney disease (PKD1). Clin Genet 1998; 53: 303-307.
6. Lu W, Peissel B, Babakhanlou H et al. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat Genet 1997; 17: 179-181.
7. Lu W, Fan X, Basora N et al. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet 1999; 21: 160-161.
8. Harris PC, Bae KT, Rossetti S et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2006; 17: 3013-3019.
9. Evan AP, McAteer JA. Cyst cells and cyst walls. In: Gardner KDJ, Bernstein J (eds). The Cystic Kidney. Kluwer: Boston, 1990, pp. 21-42.
10. Grantham JJ, Geiser JL, Evan AP. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 1987; 31: 1145-1152.
11. Grantham JJ. Polycystic kidney disease: neoplasia in disguise. Am J Kidney Dis 1990; 15: 110-116.
12. Harris PC, Watson ML. Autosomal dominant polycystic kidney disease: neoplasia in disguise? Nephrol Dial Transplant 1997; 12: 1089-1090.
13. Grantham JJ, Torres VE, Chapman AB et al. Volume progression in polycystic kidney disease. N Engl J Med 2006; 354: 2122-2130.
14. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996; 87: 979-987.
15. Brasier JL, Henske EP. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest 1997; 99: 194-199.
16. EL-Merhi FM, Bae KT. Cystic renal disease. Magn Reson Imaging Clin N Am 2004; 12: 449-467.
17. Mangoo-Karim R, Uchic M, Lechene C, Grantham JJ. Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci USA 1989; 86: 6007-6011.
18. Grantham JJ, Uchic M, Cragoe Jr EJ et al. Chemical modification of cell proliferation and fluid secretion in renal cysts. Kidney Int 1989; 35: 1379-1389.
19. Sullivan LP, Wallace DP, Gover T et al. Sulfonylurea-sensitive K(+) transport is involved in Cl(-) secretion and cyst growth by cultured ADPKD cells. J Am Soc Nephrol 2002; 13: 2619-2627.
20. Sullivan LP, Wallace DP, Grantham JJ. Epithelial transport in polycystic kidney disease. Physiol Rev 1998; 78: 1165-1191.
21. Wallace DP, Christensen M, Reif G et al. Electrolyte and fluid secretion by cultured human inner medullary collecting duct cells. Am J Physiol Renal Physiol 2002; 283: F1337-F1350.
22. Wallace DP, Grantham JJ, Sullivan LP. Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int 1996; 50: 1327-1336.
23. Cuppage FE, Huseman RA, Chapman A, Grantham JJ. Ultrastructure and function of cysts from human adult polycystic kidneys. Kidney Int 1980; 17: 372-381.
24. Huseman R, Grady A, Welling D, Grantham J. Macropuncture study of polycystic disease in adult human kidneys. Kidney Int 1980; 18: 375-385.
25. Grantham JJ. Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach. Kidney Int 2003; 64: 1157-1162.
26. Mehrara E, Forssell-Aronsson E, Ahlman H, Bernhardt P. Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Res 2007; 67: 3970-3975.
27. Sise C, Kusaka M, Wetzel LH et al. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int 2000; 58: 2492-2501.
28. Levine E, Grantham JJ. The role of computed tomography in the evaluation of adult polycystic kidney disease. Am J Kidney Dis 1981; 1: 99-105.
29. Bae KT, Commean PK, Lee J. Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease. J Comput Assist Tomogr 2000; 24: 614-619.
30. Ruggenenti P, Remuzzi A, Ondei P et al. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int 2005; 68: 206-216.
31. Welling LW, Welling DJ. Theoretical models of cyst formation and growth. Scanning Microsc 1988; 2: 1097-1102.
32. Welling LW, Welling DJ. Kinetics of cyst development in cystic renal disease. In: Cummings NB, Klahr S (eds). Chronic Renal Disease. Plenum Medical Book Company: New York, 1985, pp. 95-103.
33. Ozono S, Miyao N, Igarashi T et al. Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese society of renal cancer. Jpn J Clin Oncol 2004; 34: 82-85.
34. Belibi FA, Reif G, Wallace DP et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 2004; 66: 964-973.
35. Yamaguchi T, Nagao S, Wallace DP et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 2003; 63: 1983-1994.
36. Yamaguchi T, Pelling JC, Ramaswamy NT et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 2000; 57: 1460-1471.
37. Gattone II VH, Wang X, Harris PC, Torres VE. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 2003; 9: 1323-1326.
38. Hateboer N, Dijk MA, Bogdanova N et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 study group. Lancet 1999; 353: 103-107.
39. Magistroni R, He N, Wang K et al. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2003; 14: 1164-1174.
40. Sandhu S, Silbiger SR, Lei J, Neugarten J. Effects of sex hormones on fluid and solute transport in Madin-Darby canine kidney cells. Kidney Int 1997; 51: 1535-1539.